What is the recommended dosage of acyclovir (antiviral medication) cream for treating herpes simplex?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Acyclovir Cream Dosage for Herpes Simplex

Acyclovir cream (5%) should be applied 5 times daily for 5 days, but oral acyclovir is strongly preferred over topical formulations because topical therapy is substantially less effective and its use is discouraged. 1

Why Topical Acyclovir Is Not Recommended

  • The CDC explicitly states that topical acyclovir therapy is substantially less effective than oral formulations and its use is discouraged for treating herpes simplex infections. 1
  • Topical acyclovir provides no improvement in systemic symptoms and is significantly less effective than oral therapy. 2
  • Oral antiviral medications are significantly more effective than topical formulations for treating cold sores and genital herpes. 3

Recommended Oral Alternatives (Preferred Over Cream)

For Recurrent Herpes Labialis (Cold Sores):

  • Acyclovir 800 mg orally twice daily for 5 days (most convenient, equivalent efficacy) 3
  • Acyclovir 400 mg orally 3 times daily for 5 days 3, 4
  • Acyclovir 200 mg orally 5 times daily for 5 days 3

For First Episode Genital Herpes:

  • Acyclovir 200 mg orally 5 times daily for 7-10 days until clinical resolution 1, 2

For Recurrent Genital Herpes:

  • Acyclovir 800 mg orally twice daily for 5 days 1
  • Acyclovir 400 mg orally 3 times daily for 5 days 1
  • Acyclovir 200 mg orally 5 times daily for 5 days 1

Critical Timing Considerations

  • Treatment must be initiated during prodrome or within 2 days of lesion onset for maximum benefit. 3, 2
  • Starting therapy after this window significantly reduces effectiveness, and most immunocompetent patients with recurrent disease experience limited benefit from delayed therapy. 3
  • Early treatment can reduce pain duration by 36% and healing time by 27% when started in the prodrome or erythema stage. 5

If Topical Acyclovir Cream Must Be Used

When oral therapy is not feasible and topical acyclovir 5% cream is the only option:

  • Apply 5 times daily for 5 days, starting at earliest sign of recurrence 6, 7
  • The combination product containing 5% acyclovir plus 1% hydrocortisone cream shows superior efficacy to acyclovir cream alone, reducing both ulcerative and nonulcerative recurrences. 6, 7
  • Topical acyclovir may speed healing in immunocompromised patients with chronic ulcerative herpetic lesions when systemic therapy is not desired. 8

Special Populations Requiring Oral or IV Therapy

Immunocompromised Patients:

  • Require more aggressive therapy with acyclovir 400 mg orally 3-5 times daily or IV administration. 1, 9
  • May have prolonged episodes with extensive disease requiring IV acyclovir 5-10 mg/kg every 8 hours. 1

Severe Disease:

  • IV acyclovir 5-10 mg/kg every 8 hours for 5-7 days for hospitalized patients with disseminated infection, pneumonitis, hepatitis, or CNS complications. 1

Important Caveats

  • Acyclovir neither eradicates latent virus nor affects subsequent risk, frequency, or severity of recurrences after discontinuation. 1, 3
  • Patients should abstain from activities that might spread the virus while lesions are present, though transmission can occur during asymptomatic periods. 3, 2
  • Most immunocompetent patients with recurrent disease experience limited benefit from therapy overall. 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acyclovir Dosing for Herpes Simplex in Females

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Recommended Loading Dose of Acyclovir for Oral Herpes Outbreak

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of recurrent oral herpes simplex infections.

Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2007

Research

Treatment of recurrent herpes simplex labialis with oral acyclovir.

The Journal of infectious diseases, 1990

Research

Treatment of mucocutaneous herpes simplex infections with acyclovir.

Journal of the American Academy of Dermatology, 1988

Guideline

Acyclovir Dosing for Herpes Zoster

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.